Preoperative arterial blood gas analysis, breathing air, showed pH 7.41, PCO 2 42 mmHg, PO 2 65 mmHg, HCO 3 26 mmol·l -1 and SaO 2 93%. The patient received his medication on the morning of surgery and was given propofol-nitrous oxideatracurium anesthesia. There were no signs of respiratory obstruction intraoperatively. About 10 min after 0.6 mg glycopyrrolate and 2.5 mg neostigmine iv, SaO 2 was 85% breathing air and there were bilateral rhonchi on auscultation of chest. There were no secretions or aspirate on endotracheal suction. He was given 4 L·min -1 oxygen, hydrocortisone and aminophylline iv after which rhonchi persisted and SaO 2 was 92%. Salbutamol nebulisation and subcutaneous terbutaline improved SaO 2 to 96% on 2 L·min -1 oxygen and 93% to 94% on room air.
Postoperative bronchospasm in a patient with Parkinson's disease
To the Editor: We recently anesthetized a 50-yr-old, 55 kg, male nonsmoker with Parkinson's disease receiving 125 mg levodopa and 12.5 mg carbidopa six hourly. He had bilateral abductor cord palsy for which laser arytenoidectomy was planned. A tracheostomy was done one month before this admission for an acute episode of breathlessness. Patients with Parkinson's disease are known to have vocal cord paralysis and laryngeal spasm. 1, 2 Preoperative arterial blood gas analysis, breathing air, showed pH 7.41, PCO 2 42 mmHg, PO 2 65 mmHg, HCO 3 26 mmol·l -1 and SaO 2 93%. The patient received his medication on the morning of surgery and was given propofol-nitrous oxideatracurium anesthesia. There were no signs of respiratory obstruction intraoperatively. About 10 min after 0.6 mg glycopyrrolate and 2.5 mg neostigmine iv, SaO 2 was 85% breathing air and there were bilateral rhonchi on auscultation of chest. There were no secretions or aspirate on endotracheal suction. He was given 4 L·min -1 oxygen, hydrocortisone and aminophylline iv after which rhonchi persisted and SaO 2 was 92%. Salbutamol nebulisation and subcutaneous terbutaline improved SaO 2 to 96% on 2 L·min -1 oxygen and 93% to 94% on room air.
Glycopyrrolate offers protection against neostigmine induced bronchoconstriction in normal subjects. 3 Patients with Parkinson's disease have obstructive dysfunction probably caused by parasympathetic hyperactivity. 4 Parasympathetic hyperactivity may make them susceptible to the muscarinic effects of neostigmine and probably caused the postoperative bronchospasm in our patient. The adequacy of glycopyrrolate in protecting against muscarinic effects of neostigmine in patients with Parkinson's disease deserves further study. 
Hidden misconnection of the pulse oximeter probe on a Siemens Medical Systems, Inc. KION™ anesthesia machine
To the Editor: Recently we found that the pulse oximeter probe on a new Siemens Medical Systems, Inc. KION™ anesthesia machine was not working. The probe seemed to be correctly connected, both on visual inspection and during a gentle "tug test". However, the light on the finger probe was not lit, and no O 2 saturation trace could be displayed on the monitor. Eventually we noticed that there was a junction between the pulse oximeter probe and the KION™ anesthesia machine. It was possible to separate this connection, rotate one half through 180, and reattach it. The pulse oximeter then worked perfectly.
In the incorrect position, the connecter protrudes about 1 mm from the junction box, while the correctly positioned connector fits flush. Also, the patient end of the clamp connecting the two parts is elevated only if the parts are incorrectly connected (Figure) . There are no markings on the connector to show which way is correct, and the clamp holds the connection together fairly well, even in the incorrect position.
Siemens Medical Systems, Inc. should redesign the connection so that it is impossible to inadvertently misconnect the pulse oximeter. Until that is done, we hope that this letter will make it easier for other KION™ users to diagnose and treat a hidden misconnection of the pulse oximeter probe.
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